BRPI0719549B8 - composição para administração de princípios biologicamente ativos no âmbito ginecológico e retal, e usos para as mesmas - Google Patents
composição para administração de princípios biologicamente ativos no âmbito ginecológico e retal, e usos para as mesmasInfo
- Publication number
- BRPI0719549B8 BRPI0719549B8 BRPI0719549A BRPI0719549A BRPI0719549B8 BR PI0719549 B8 BRPI0719549 B8 BR PI0719549B8 BR PI0719549 A BRPI0719549 A BR PI0719549A BR PI0719549 A BRPI0719549 A BR PI0719549A BR PI0719549 B8 BRPI0719549 B8 BR PI0719549B8
- Authority
- BR
- Brazil
- Prior art keywords
- composition
- gynecological
- rectal
- administration
- biologically active
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI2006A002286 | 2006-11-28 | ||
IT002286A ITMI20062286A1 (it) | 2006-11-28 | 2006-11-28 | Una composizione per la somministrazione di principi biologicamente attivi in ambito ginecologico e rettale nonche' i suoi usi |
PCT/IB2007/003491 WO2008065492A2 (en) | 2006-11-28 | 2007-11-12 | A composition for the administration of biologically active principles in gynaecologic and rectal field and uses thereof |
Publications (3)
Publication Number | Publication Date |
---|---|
BRPI0719549A2 BRPI0719549A2 (pt) | 2014-01-21 |
BRPI0719549B1 BRPI0719549B1 (pt) | 2020-05-19 |
BRPI0719549B8 true BRPI0719549B8 (pt) | 2021-05-25 |
Family
ID=39468316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0719549A BRPI0719549B8 (pt) | 2006-11-28 | 2007-11-12 | composição para administração de princípios biologicamente ativos no âmbito ginecológico e retal, e usos para as mesmas |
Country Status (11)
Country | Link |
---|---|
US (1) | US20100092440A1 (pt) |
EP (1) | EP2120864B1 (pt) |
JP (1) | JP5535641B2 (pt) |
BR (1) | BRPI0719549B8 (pt) |
CA (1) | CA2670578C (pt) |
DK (1) | DK2120864T3 (pt) |
ES (1) | ES2626841T3 (pt) |
IT (1) | ITMI20062286A1 (pt) |
PL (1) | PL2120864T3 (pt) |
RU (1) | RU2445073C2 (pt) |
WO (1) | WO2008065492A2 (pt) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1403661B1 (it) * | 2011-01-28 | 2013-10-31 | Probiotical Spa | Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali. |
ITMI20110791A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri in grado di metabolizzare gli ossalati. |
ITMI20110792A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia. |
ITMI20110793A1 (it) | 2011-05-09 | 2012-11-10 | Probiotical Spa | Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati. |
ITRM20110477A1 (it) | 2011-09-09 | 2013-03-10 | Giovanni Mogna | Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell |
ITMI20111718A1 (it) | 2011-09-23 | 2013-03-24 | Probiotical Spa | Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali. |
EP2809301A1 (en) | 2012-01-31 | 2014-12-10 | Biosoma B.V. | Method for administration of a probiotic |
ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
ITMI20130794A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle vaginosi batteriche. |
ITMI20130795A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat |
ITMI20131280A1 (it) * | 2013-07-30 | 2015-01-31 | Probiotical Spa | Produzione di materie prime e prodotti finiti atossici testati mediante un metodo innovativo a base di batteri probiotici per la determinazione della tossicità verso i batteri probiotici. |
WO2016020861A2 (pt) * | 2014-08-05 | 2016-02-11 | Palmeira De Oliveira Ana Cristina | Composição vaginal para tratamento e prevenção de infeções urogenitais, processos de obtenção e suas aplicações |
AU2017376780A1 (en) | 2016-12-15 | 2019-07-04 | Novome Biotechnologies, Inc. | Compositions and methods for modulating growth of a genetically modified gut bacterial cell |
MX2021008072A (es) | 2019-01-18 | 2021-08-16 | Cp Kelco Us Inc | Composicion prebiotica y su uso. |
CN112813011A (zh) * | 2021-03-23 | 2021-05-18 | 北京宝源广通科技发展有限公司 | 一种干酪乳杆菌及其在制备水苏糖合生元酸奶中的应用 |
CN113558246B (zh) * | 2021-07-21 | 2023-10-20 | 石河子大学 | 一种共生双歧杆菌复合微胶囊及制备方法 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK242083D0 (da) * | 1983-05-27 | 1983-05-27 | Hansens Chr Bio Syst | Vaginalkapsler |
JPH06101994B2 (ja) * | 1989-08-16 | 1994-12-14 | ユニコロイド株式会社 | 耐消化性腸内有用細菌及びその製法 |
DE4123330A1 (de) * | 1991-07-15 | 1993-01-21 | Gerhard Netz | Verfahren zur peranalen keimapplikation |
JPH05262657A (ja) * | 1992-01-22 | 1993-10-12 | Miyarisan Seibutsu Igaku Kenkyusho:Kk | 酪酸菌含有液剤の製造法 |
US5292534A (en) * | 1992-03-25 | 1994-03-08 | Valentine Enterprises, Inc. | Sustained release composition and method utilizing xanthan gum and an active ingredient |
US5531989A (en) * | 1994-10-28 | 1996-07-02 | Metagenics, Inc. | Immunoglobulin and fiber-containing composition for human gastrointestinal health |
US6093394A (en) * | 1997-04-11 | 2000-07-25 | Gynelogix, Inc. | Vaginal lactobacillus medicant |
JPH1121231A (ja) * | 1997-07-03 | 1999-01-26 | Okamoto Ind Inc | 水溶性潤滑剤 |
DE69802260T2 (de) * | 1998-04-30 | 2002-07-04 | Vesely Renata Maria Cavaliere | Pharmazeutische Zusammensetzungen enthaltend Lactobacillus brevis und Lactobacillus salivarius zur Behandlung von Vaginainfektionen |
JP2003128588A (ja) * | 2001-08-10 | 2003-05-08 | Toray Ind Inc | 多糖類含有組成物およびその用途 |
WO2003026687A1 (en) * | 2001-09-28 | 2003-04-03 | Nutraceutix, Inc. | Delivery system for biological component |
WO2005060937A1 (en) * | 2003-12-23 | 2005-07-07 | Chr. Hansen A/S | Compressed tablets comprising viable probiotic microorganisms |
-
2006
- 2006-11-28 IT IT002286A patent/ITMI20062286A1/it unknown
-
2007
- 2007-11-12 US US12/516,512 patent/US20100092440A1/en not_active Abandoned
- 2007-11-12 CA CA2670578A patent/CA2670578C/en not_active Expired - Fee Related
- 2007-11-12 PL PL07825668T patent/PL2120864T3/pl unknown
- 2007-11-12 DK DK07825668.2T patent/DK2120864T3/en active
- 2007-11-12 EP EP07825668.2A patent/EP2120864B1/en not_active Not-in-force
- 2007-11-12 WO PCT/IB2007/003491 patent/WO2008065492A2/en active Application Filing
- 2007-11-12 ES ES07825668.2T patent/ES2626841T3/es active Active
- 2007-11-12 RU RU2009121623/15A patent/RU2445073C2/ru active
- 2007-11-12 BR BRPI0719549A patent/BRPI0719549B8/pt not_active IP Right Cessation
- 2007-11-12 JP JP2009538800A patent/JP5535641B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2008065492A3 (en) | 2009-03-19 |
EP2120864B1 (en) | 2017-03-22 |
BRPI0719549A2 (pt) | 2014-01-21 |
JP5535641B2 (ja) | 2014-07-02 |
PL2120864T3 (pl) | 2017-08-31 |
JP2010511033A (ja) | 2010-04-08 |
WO2008065492A2 (en) | 2008-06-05 |
BRPI0719549B1 (pt) | 2020-05-19 |
DK2120864T3 (en) | 2017-05-01 |
ITMI20062286A1 (it) | 2008-05-29 |
US20100092440A1 (en) | 2010-04-15 |
RU2445073C2 (ru) | 2012-03-20 |
EP2120864A2 (en) | 2009-11-25 |
CA2670578C (en) | 2016-01-26 |
RU2009121623A (ru) | 2011-01-10 |
ES2626841T3 (es) | 2017-07-26 |
CA2670578A1 (en) | 2008-06-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0719549B8 (pt) | composição para administração de princípios biologicamente ativos no âmbito ginecológico e retal, e usos para as mesmas | |
Musah et al. | Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip | |
Patel et al. | Enhanced extracellular vesicle production and ethanol-mediated vascularization bioactivity via a 3D-printed scaffold-perfusion bioreactor system | |
Han et al. | Extracellular matrix-based cryogels for cartilage tissue engineering | |
Marzorati et al. | The HMI™ module: a new tool to study the Host-Microbiota Interaction in the human gastrointestinal tract in vitro | |
Caliari et al. | Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation | |
EA202191313A1 (ru) | Композиции на основе липидных наночастиц | |
BR112016022553A2 (pt) | Compostos e métodos para entrega transmembrana de moléculas? | |
BR112018003316A2 (pt) | compostos e métodos para entrega transmembrana de moléculas | |
AR061929A1 (es) | Acidos nucleicos de union al factor derivado de celulas estomales sdf-1 | |
AR090898A1 (es) | Una formulacion de farmaco de liberacion retardada | |
Vivcharenko et al. | Highly porous and superabsorbent biomaterial made of marine-derived polysaccharides and ascorbic acid as an optimal dressing for exuding wound management | |
Huang et al. | Promoted chondrogenesis of cocultured chondrocytes and mesenchymal stem cells under hypoxia using in-situ forming degradable hydrogel scaffolds | |
HRP20170611T1 (hr) | Vaginaleta koja sadrži mliječnu kiselinu | |
AR060786A1 (es) | Variaciones cristalinas de (2s)-(4e)-n-metil-5-[3-(5-isopropoxipiridin)il]-4-penten-2-amina | |
Shokrani et al. | Cell-seeded biomaterial scaffolds: the urgent need for unanswered accelerated angiogenesis | |
Thakurta et al. | Growth factor and ultrasound-assisted bioreactor synergism for human mesenchymal stem cell chondrogenesis | |
Carson et al. | The vaginal microbiota, bacterial biofilms and polymeric drug-releasing vaginal rings | |
AR108729A1 (es) | Forma farmacéutica de unidades múltiples que comprende un núcleo con unidades centrales individuales cubiertas por un material muco-adhesivo, y un recubrimiento de núcleo entérico | |
BR112012013325A2 (pt) | Composição farmacêutica e uso | |
Yang et al. | Ultra-durable cell-free bioactive hydrogel with fast shape memory and on-demand drug release for cartilage regeneration | |
Feng et al. | Mycoplasma contamination affects cell characteristics and decreases the sensitivity of BV2 microglia to LPS stimulation | |
Vargas-Alfredo et al. | Synthesis and modification of gelatin methacryloyl (GelMA) with antibacterial quaternary groups and its potential for periodontal applications | |
Trombino et al. | Polymeric based hydrogel membranes for biomedical applications | |
Gögele et al. | Biodegradable Poly (DL-lactide-co-glycolide)(PLGA)-Infiltrated Bioactive Glass (CAR12N) Scaffolds Maintain Mesenchymal Stem Cell Chondrogenesis for Cartilage Tissue Engineering |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 19/05/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 12/11/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 15A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2696 DE 06-09-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |